Julie Makani/LinkedIn
May 25, 2026, 15:28
Julie Makani: African Health Science Partnerships at INTEREST 2026
Julie Makani, Science Advisor at East Central and Southern Africa Health Community, shared a post on LinkedIn:
“Meetings at the INTEREST Conference in 2026
Speakers:
- Dr Nyaradzo Mgodi, University of Zimbabwe
- Prof Julie Makani, MUHAS
Health Science in Africa: Zimbabwe and Tanzania
Discussion on potential partnership opportunities involving SickleInAfrica, ACRN, and GGTI (Global Gene Therapy Initiative), focusing on sickle cell disease (SCD) and HIV.
INTEREST 2026 in Dar-es-Salaam.
12-15 May 2026.
International Conference on HIV Treatment, Pathogenesis, and Prevention Research in Resource-Limited Settings (INTEREST Conference).”
Find more posts featuring Julie Makani on Hemostasis Today.
-
Aug 31, 2026, 14:03Adil Aftab: Anticoagulation in CKD – Key Updates from the 2026 ESC Guidelines
-
Aug 31, 2026, 14:01Isa Oboirien: Why Might Factor XI Inhibition Work Differently in Stroke and ACS?
-
Aug 31, 2026, 13:55Mike Morrissey: Advancing Europe’s Cardiovascular Health Agenda at ESC Congress 2026
-
Aug 31, 2026, 13:44Penilla Gunther: Patient Voices Take Center Stage in Cardiovascular Prevention at ESC Congress 2026
-
Aug 31, 2026, 13:42Mohamed Saleh Gomaa: Master the Latest in PE Management
-
Aug 31, 2026, 13:38Lyn Kleinbach-Reilly: A New Standard for Coagulation Testing in Neonatal Care
-
Aug 31, 2026, 13:36Rafael Gomes: Can Prasugrel Replace Ticagrelor in ACS Treatment?
-
Aug 31, 2026, 05:35Does LDL Cholesterol Influence VTE Risk? – Ordo Fraterna Fibonacci
-
Aug 31, 2026, 05:19Tania Ahuja: Apixaban in Abdominal Transplant Patients